-
Two oral medications for relapsing-remitting MS in phase III development; antihypertensives find new uses; Ginkgo biloba does not prevent cognitive decline in elderly; and FDA Actions.
-
Valproic acid and phenytoin were equally effective in the treatment of acute repetitive seizures and status epilepticus.
-
There are no randomized controlled treatment trials of cervical artery dissection, and the most effective therapy is uncertain.
-
5-α reductase inhibitors and hip fracture in men; the effects of drug-reimbursement policy on outcomes; new guidelines for type 2 diabetes; beta-blocker-associated brady-cardia is linked to CVD events; FDA Updates.
-
Anxiety is a common but underrecognized symptom of Parkinson's disease, for which there are a number of suggested but no recommended rating scales.
-
Fourteen cases of the rare and difficult to treat "painful legs and moving toes" syndrome are presented. The cases included diverse etiologies—polyneuropathy, radiculopathy, or neuroleptic use—and half responded to GABAergic medications.
-
Axonal sensory neuropathy is a common complication of thalidomide therapy and occurs at a lower than expected dose in patients with cutaneous lupus.
-
Needle EMG is a safe procedure in patients who are taking antiplatelet or warfarin therapy.
-
-
Neuromyelitis optica (NMO) may be a unique central nervous system demyelinating disease with distinct clinical and MRI manifestations, as well as different immune and pathological characteristics as compared to multiple sclerosis (MS).
